Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.
Best Pract Res Clin Endocrinol Metab
; 31(3): 349-361, 2017 06.
Article
in En
| MEDLINE
| ID: mdl-28911730
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Carcinoma, Neuroendocrine
/
Protein Kinase Inhibitors
/
Drug-Related Side Effects and Adverse Reactions
Type of study:
Diagnostic_studies
/
Guideline
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Best Pract Res Clin Endocrinol Metab
Year:
2017
Document type:
Article